| Literature DB >> 30813607 |
Aracely Serrano-Medina1, Angel Ugalde-Lizárraga2, Michelle Stephanie Bojorquez-Cuevas3, Jatniel Garnica-Ruiz4, Martín Alexis González-Corral5, Arnold García-Ledezma6, Gisela Pineda-García7, José Manuel Cornejo-Bravo8.
Abstract
This study aims to determine the degree of acetylcholinesterase inhibition and neurological symptoms for each of the psychiatric disorders diagnosed in the farm workers of a rural population in the state of Baja California, Mexico. We conducted a cross-sectional study on 140 agricultural workers (exposed participants). The study was run using the Mini International Neuropsychiatric Interview Diagnostic Test (MINI), a pre-established questionnaire to diagnose the mental state of each agricultural worker. Analysis of enzymatic activity was carried out using the modified Ellman method. The results showed that, among agricultural workers with slightly inhibited enzymatic activity, 25% met the criteria for the diagnosis of major depression with suicidal attitudes, 23.9% with inhibited enzymatic activity showed generalized anxiety, 23.5% showed combined depression⁻anxiety, and 22% met the criteria for major depression and no psychiatric diagnosis disorder. These results suggest the need for the development of effective public-health strategies to inform farm workers about integrated pesticide management in order to prevent serious health complications.Entities:
Keywords: acetylcholinesterase; mental disorders; neurotoxicity; organophosphates; pesticides
Mesh:
Substances:
Year: 2019 PMID: 30813607 PMCID: PMC6427808 DOI: 10.3390/ijerph16050689
Source DB: PubMed Journal: Int J Environ Res Public Health ISSN: 1660-4601 Impact factor: 3.390
Sociodemographic characteristics of the general study population. p-values were obtained with the Chi-Square test. p < 0.05 was considered statistically significant.
| Variable | Nonexposed ( | Exposed ( |
| ||
|---|---|---|---|---|---|
|
| % |
| % | ||
| Age (Years) | 0.000 | ||||
| 18–34 | 89 | 89.0 | 84 | 60 | |
| 35–50 | 9 | 9.0 | 52 | 37.1 | |
| >51 | 2 | 2.0 | 4 | 2.9 | |
| Gender | 0.751 | ||||
| Female | 60 | 60.0 | 88 | 62.9 | |
| Male | 40 | 40.0 | 52 | 37.1 | |
| Education | 0.000 | ||||
| Illiterate | 0 | 0 | 12 | 8.6 | |
| Elementary school | 1 | 1.0 | 78 | 55.7 | |
| Middle school | 2 | 2.0 | 38 | 27.1 | |
| High school | 0 | 0 | 10 | 7.1 | |
| College | 97 | 97 | 2 | 1.4 | |
| Marital status | 0.000 | ||||
| Single | 60 | 60.0 | 20 | 14.3 | |
| Free union | 35 | 35.0 | 68 | 48.6 | |
| Married | 4 | 4.0 | 48 | 34.3 | |
| Divorced | 1 | 1.0 | 0 | 0 | |
| Widowed | 0 | 0 | 4 | 2.9 | |
| Occupation | 0.000 | ||||
| Farmworker | 20 | 20.0 | 140 | 100.0 | |
| Student | 80 | 80.0 | 0 | 0 | |
| Place of residence in the last six months | 0.000 | ||||
| Provincial center | 100 | 100.0 | 0 | 0 | |
| Surrounding village | 0 | 0 | 140 | 100.0 | |
| Smokers | 23 | 23.0 | 22 | 15.7 | 0.040 |
| Alcohol drinkers | 54 | 54.0 | 24 | 17.4 | 0.000 |
| Abuse substances | 0.190 | ||||
| Cocaine | 3 | 3.0 | 4 | 2.8 | |
| Heroin | 0 | 0 | 3 | 2.1 | |
| Marihuana | 5 | 5.0 | 12 | 8.6 | |
| Crystal | 1 | 1.0 | 11 | 7.9 | |
| No abuse substances | 91 | 91.0 | 110 | 78.6 | |
| Diagnosed psychiatric disorder | 0.000 | ||||
| Depression | 3 | 3.0 | 20 | 14.3 | |
| Major depression with suicidal risk | 8 | 8.0 | 44 | 31.4 | |
| Generalized anxiety | 18 | 18.0 | 20 | 14.3 | |
| Depression–generalized anxiety | 7 | 7.0 | 20 | 14.3 | |
| No psychiatric-disorder diagnosis | 64 | 64.0 | 36 | 25.7 | |
Acethylcholinestease activity data of the general study population. The p-values for each parameter were obtained by factorial ANOVA, and p < 0.05 was considered statistically significant.
| Parameter | Nonexposed (Mean ± SD) | Exposed (Mean ± SD) |
|
|
|---|---|---|---|---|
| Hb (g/dL) | 21.8 | 0.000 * | ||
| Female | 12.72 ±1.07 | 12.66 ± 2.25 | ||
| Male | 15.15 ± 0.90 | 13.74 ± 2.54 | ||
| AChE (mU/μLHb) | 33.2 | 0.000 * | ||
| Female | 582.43 ± 53.63 | 435.69 ± 103.28 | ||
| Male | 485.39 ± 40.78 | 398.99 ± 84.89 | ||
| AChE activity (mE/min) | 227.95 ± 10.19 | 178.88 ± 37.48 | 126.9 | 0.000 |
| AChE activity (%) | 97.53 ± 4.33 | 76.39 ± 15.93 | 126.9 | 0.000 |
| AChE inhibition (%) | 2.4 ± 4.33 | 23.32 ± 15.92 | 126.9 | 0.000 |
* The interaction between sex and group (exposed vs. unexposed) was significant at the 0.05 level.
Organophosphate pesticides commonly used by the study population. World Health Organization classification: Class IA, extremely hazardous; Class IB, highly hazardous; Class II, toxic; Class III, moderately toxic.
| Pesticide Name | WHO * Classification |
|---|---|
| Azinphos-methyl | IB |
| Chlorpyrifos | III |
| Dicofol | II |
| Malathion | III |
| Methamidophos | IB |
| Methyl parathion | IA |
| Phosmet | II |
* World Health Organization.
Risk of toxicity and neurological symptoms of the exposed participants diagnosed with psychiatric disorders. p-values were obtained by the Chi-Square test. p < 0.05 was considered statistically significant. The percentage was calculated concerning the exposed participants. Percentages were determined concerning the total of the exposed participants.
| Variable ( | Depression Disorder | Suicidal Attempt | Generalized Anxiety | Depression and Generalized Anxiety | No Psychiatric Diagnosis Disorder |
|
|---|---|---|---|---|---|---|
| Weekly pesticide exposure time in hours ( | ||||||
| 30–60 | (16) 11.4 | (40) 28.6 | (14) 10.0 | (20) 14.3 | (32) 22.9 | 0.045 |
| 61–90 | (4) 2.9 | (4) 2.9 | (6) 4.3 | (4) 2.9 | ||
| Annual pesticide-exposure time in years ( | ||||||
| 0.5–1 | (12) 8.6 | (22) 15.7 | (12) 8.6 | (10) 7.1 | (22) 15.7 | 0.113 |
| 2–9 | (8) 5.7 | (20) 14.3 | (6) 4.3 | (10) 7.1 | (8) 5.7 | |
| 10–20 | (0)0 | (2) 1.4 | (2) 1.4 | (0) 0 | (6) 4.3 | |
| Neurological symptoms ( | ||||||
| Shoulder pain | (6) 4.3 | (28) 20 | (2) 1.4 | (14) 10 | (18) 12.9 | 0.001 |
| Back pain | (10) 7.1 | (34) 24.3 | (10) 7.1 | (18) 12.9 | (18) 12.9 | 0.003 |
| Numbness | (6) 4.3 | (24) 17.1 | (8) 5.7 | (14) 10 | (20) 14.3 | 0.095 |
| Nocturia | (4) 2.9 | (18) 12.9 | (6) 4.3 | (6) 4.3 | (14) 10 | 0.504 |
| Dyspnea | (4) 2.9 | (16) 11.4 | (4) 2.9 | (10) 7.1 | (10) 7.1 | 0.175 |
| Insomnia | (2) 1.4 | (12) 8.6 | (4) 2.9 | (8) 5.7 | (10) 7.1 | 0.267 |
| Dizzines | (10) 7.1 | (30) 21.4 | (2) 1.4 | (14) 10 | (16) 11.4 | 0.001 |
| Abdominal discomfort | (8) 5.7 | (23) 16.4 | (0) 0 | (12) 8.6 | (14) 10 | 0.001 |
Acethylcholinesterase activities of the study population diagnosed with different psychiatric disorders. The p-values for each parameter were obtained by factorial ANOVA, and p < 0.05 was considered statistically significant.
| Psychiatric Disorders | Acethylcholinesterase Activity Values | |||
|---|---|---|---|---|
| Specific Activity, mU/μLHb | Activity, mE/min (Mean ± SD) | % Activity (Mean ± SD) | % Inhibition | |
| Depression disorder | ||||
| Exposed | 436.49 ± 85.66 | 181.85 ± 22.85 | 77.94 ± 9.70 | 22.06 ± 9.71 |
| Nonexposed | 481.31 ± 117.60 | 208.93 ± 33.71 | 89.45 ± 14.32 | 10.55 ± 14.32 |
|
| 0.377 | 0.057 | 0.057 | 0.057 |
| Major depression with suicidal risk | ||||
| Exposed | 414.34 ± 92.75 | 174.89 ± 32.33 | 74.99 ± 13.74 | 25.01 ± 13.73 |
| Nonexposed | 555.86 ± 55.25 | 228.43 ± 7.27 | 97.73 ± 3.08 | 2.27 ± 3.09 |
|
| 0.000 | 0.000 | 0.000 | 0.000 |
| Generalized anxiety | ||||
| Exposed | 388.62 ± 90.04 | 177.48 ± 39.87 | 76.08 ± 16.94 | 23.91 ± 16.94 |
| Nonexposed | 553.44 ± 72.42 | 228.11 ± 7.34 | 97.60 ± 3.12 | 2.340 ± 3.12 |
|
| 0.000 | 0.000 | 0.000 | 0.000 |
| Depression and generalized anxiety | ||||
| Exposed | 421.66 ± 106.27 | 178.23 ± 48.70 | 76.40 ± 20.69 | 23.59 ± 20.69 |
| Nonexposed | 566.99 ± 78.36 | 225.71 ± 8.20 | 96.58 ± 3.49 | 3.42 ± 3.49 |
|
| 0.003 | 0.000 | 0.000 | 0.000 |
| Without a psychiatric diagnosis | ||||
| Exposed | 440.25 ± 108.81 | 181.96 ± 42.73 | 76.54 ± 15.93 | 22.01 ± 18.15 |
| Nonexposed | 539.75 ± 63.44 | 229.28 ± 7.65 | 98.09 ± 3.25 | 1.91 ± 3.25 |
|
| 0.000 | 0.000 | 0.000 | 0.000 |
Figure 1Comparison levels of % inhibition (•) and AChE activity (♦)% of the exposed participants. Data are represented as the mean ± SD.